PreprintAll rights reservedmedRxiv
CSF Alzheimer's Disease Biomarkers in Relation to Functional Status and Tofersen Treatment Response in ALS
Related
- A neurocognitive speech taxonomy for voice biomarkers of Alzheimer's disease
- Global research trends and hotspots in blood-based biomarkers for Alzheimer’s disease: a bibliometric analysis
- SPLASH: a benchtop platform for accessible, ultrasensitive quantification of plasma biomarkers in Alzheimer’s disease
- Alzheimer’s Disease Neuropathology Plasma Biomarkers and Cognition in a Midlife Diverse Community-Based Cohort
- Alzheimer's Disease Biomarkers Measured by Capillary Blood Collection Versus Venous Plasma and Cerebrospinal Fluid
BibTeX
@misc{eberle2026alzheimers,
title = {{CSF Alzheimer's Disease Biomarkers in Relation to Functional Status and Tofersen Treatment Response in ALS}},
author = {F. Eberle and S. Bersen and F. Rachel and C. Widmann and P. Weydt and S. Castro Gomez},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.26.26366525},
url = {https://www.medrxiv.org/content/10.64898/2026.10.26.26366525v1},
}
RIS
TY - UNPB
TI - CSF Alzheimer's Disease Biomarkers in Relation to Functional Status and Tofersen Treatment Response in ALS
AU - F. Eberle
AU - S. Bersen
AU - F. Rachel
AU - C. Widmann
AU - P. Weydt
AU - S. Castro Gomez
PY - 2026
DA - 2026/10/26
PB - medRxiv
DO - 10.64898/2026.10.26.26366525
UR - https://www.medrxiv.org/content/10.64898/2026.10.26.26366525v1
ER -